However, there are no reports on the effect of any GLP-1 RAs on Ang 1–7, 1–9, ACE 2, or aldosterone levels in patients with MS or T2D in relation to cardiac phenotype protection. This evidence concerns the gene GLP1R and myeloid sarcoma.